NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX)

CUSIP: 64125C109

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
99,963,154
Total 13F shares
92,001,152
Share change
+219,844
Total reported value
$10,350,228,156
Put/Call ratio
82%
Price per share
$112.50
Number of holders
508
Value change
+$38,916,412
Number of buys
236
Number of sells
226

Quarterly Holders Quick Answers

What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q3 2023

As of 30 Sep 2023, NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by 508 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 92,001,152 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Bellevue Group AG, Point72 Asset Management, L.P., MORGAN STANLEY, JPMORGAN CHASE & CO, JANUS HENDERSON GROUP PLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 509 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.